This is a past event. Registration is closed. View other ECCP events.

Event Details

With the eased COVID-19 protocols and restrictions, the unsettling possibility of another outbreak is still something that must be put into consideration, particularly with the election underway. Threats from multiple variants developing and surges certainly are indications that full complacency is yet an option. Together, as we're now opening economies again, workplace safety and employees' well-being surely are key aspects for us to recover and sustain our business operations.

Abbott, a global leader in healthcare and diagnostics, is committed to maintaining the health and protection of communities just as it has been at the forefront in fighting the COVID-19 pandemic. Through their innovation - the Panbio COVID-19 Antigen Rapid Test - they aim to bring an accessible, affordable, and efficient method of COVID-19 testing to the public.

Join us on May 25, 2022 10:00 AM - 11:30 AM (GMT +8) as we engage in relevant discourse with Abbott's Regional Business Manager APAC, Ms. Subah Nadarajan, on this timely product as well as the importance of testing and company preparedness to ensure a safe transition back to a physical working environment. Key points to be discussed are the following:

  • Overview of the COVID-19 situation in the Philippines
  • Diagnostic tests used for the COVID-19 pandemic response
  • Understanding Antigen test results
  • Introduction to The Panbio COVID-19 Ag Rapid Test
  • Reliability of The Panbio COVID-19 Ag Rapid Test

May 25, 2022

10 AM - 11:30 AM (GMT+8)

Add to Calendar

via ZOOM


  • Subah Nadarajan (Regional Business Manager APAC at Abbott)

    Subah Nadarajan

    Regional Business Manager APAC at Abbott

    Read Bio
  • Dr. Mohan Ravuru (Director, Medical and Scientific Affairs, APAC of Abbott)

    Dr. Mohan Ravuru

    Director, Medical and Scientific Affairs, APAC of Abbott

    Read Bio


ECCP Member
ECCP Non-Member